Literature DB >> 25746971

In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing.

Nikolaos Douladiris1, Birgit Linhart2, Ines Swoboda3, Antonia Gstöttner3, Emilia Vassilopoulou4, Frank Stolz5, Rudolf Valenta3, Nikolaos G Papadopoulos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25746971      PMCID： PMC6597366          DOI： 10.1016/j.jaci.2015.01.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

Review 1.  ICON: food allergy.

Authors:  A Wesley Burks; Mimi Tang; Scott Sicherer; Antonella Muraro; Philippe A Eigenmann; Motohiro Ebisawa; Alessandro Fiocchi; Wen Chiang; Kirsten Beyer; Robert Wood; Jonathan Hourihane; Stacie M Jones; Gideon Lack; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2012-02-23       Impact factor: 10.793

Review 2.  Fish and shellfish allergy in children: review of a persistent food allergy.

Authors:  Sophia Tsabouri; Maria Triga; Michael Makris; Dimitris Kalogeromitros; Martin K Church; Kostas N Priftis
Journal:  Pediatr Allergy Immunol       Date:  2012-05-03       Impact factor: 6.377

3.  Parvalbumin, a cross-reactive fish allergen, contains IgE-binding epitopes sensitive to periodate treatment and Ca2+ depletion.

Authors:  A Bugajska-Schretter; L Elfman; T Fuchs; S Kapiotis; H Rumpold; R Valenta; S Spitzauer
Journal:  J Allergy Clin Immunol       Date:  1998-01       Impact factor: 10.793

4.  Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy.

Authors:  Ines Swoboda; Agnes Bugajska-Schretter; Petra Verdino; Walter Keller; Wolfgang R Sperr; Peter Valent; Rudolf Valenta; Susanne Spitzauer
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

5.  A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy.

Authors:  Ines Swoboda; Agnes Bugajska-Schretter; Birgit Linhart; Petra Verdino; Walter Keller; Ulrike Schulmeister; Wolfgang R Sperr; Peter Valent; Gabriel Peltre; Santiago Quirce; Nikolaos Douladiris; Nikolaos G Papadopoulos; Rudolf Valenta; Susanne Spitzauer
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

Review 6.  Anaphylaxis and emergency treatment.

Authors:  Hugh A Sampson
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

7.  FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.

Authors:  Laurian Zuidmeer-Jongejan; Montserrat Fernandez-Rivas; Lars K Poulsen; Angela Neubauer; Juan Asturias; Lars Blom; Joyce Boye; Carsten Bindslev-Jensen; Michael Clausen; Rosa Ferrara; Paula Garosi; Hans Huber; Bettina M Jensen; Stef Koppelman; Marek L Kowalski; Anna Lewandowska-Polak; Birgit Linhart; Bernard Maillere; Adriano Mari; Alberto Martinez; Clare En Mills; Claudio Nicoletti; Dirk-Jan Opstelten; Nikos G Papadopoulos; Antonio Portoles; Neil Rigby; Enrico Scala; Heidi J Schnoor; Sigurveig T Sigurdardottir; George Stavroulakis; Frank Stolz; Ines Swoboda; Rudolf Valenta; Rob van den Hout; Serge A Versteeg; Marianne Witten; Ronald van Ree
Journal:  Clin Transl Allergy       Date:  2012-03-09       Impact factor: 5.871

8.  Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

Authors:  Laurian Zuidmeer-Jongejan; Hans Huber; Ines Swoboda; Neil Rigby; Serge A Versteeg; Bettina M Jensen; Suzanne Quaak; Jaap H Akkerdaas; Lars Blom; Juan Asturias; Carsten Bindslev-Jensen; Maria L Bernardi; Michael Clausen; Rosa Ferrara; Martina Hauer; Jet Heyse; Stephan Kopp; Marek L Kowalski; Anna Lewandowska-Polak; Birgit Linhart; Bernhard Maderegger; Bernard Maillere; Adriano Mari; Alberto Martinez; E N Clare Mills; Angela Neubauer; Claudio Nicoletti; Nikolaos G Papadopoulos; Antonio Portoles; Ville Ranta-Panula; Sara Santos-Magadan; Heidi J Schnoor; Sigurveig T Sigurdardottir; Per Stahl-Skov; George Stavroulakis; Georg Stegfellner; Sonia Vázquez-Cortés; Marianne Witten; Frank Stolz; Lars K Poulsen; Montserrat Fernandez-Rivas; Rudolf Valenta; Ronald van Ree
Journal:  Int Arch Allergy Immunol       Date:  2015-02-28       Impact factor: 2.749
  8 in total
  8 in total

Review 1.  From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack.

Authors:  Verena Fuhrmann; Huey-Jy Huang; Aysegul Akarsu; Igor Shilovskiy; Olga Elisyutina; Musa Khaitov; Marianne van Hage; Birgit Linhart; Margarete Focke-Tejkl; Rudolf Valenta; Bulent Enis Sekerel
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 2.  Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.

Authors:  Rudolf Valenta; Raffaela Campana; Margit Focke-Tejkl; Verena Niederberger
Journal:  J Allergy Clin Immunol       Date:  2016-02       Impact factor: 10.793

3.  Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy.

Authors:  Raphaela Freidl; Antonia Gstoettner; Ulrike Baranyi; Ines Swoboda; Frank Stolz; Margarete Focke-Tejkl; Thomas Wekerle; Ronald van Ree; Rudolf Valenta; Birgit Linhart
Journal:  J Allergy Clin Immunol       Date:  2016-11-19       Impact factor: 10.793

Review 4.  Recombinant allergens for immunotherapy: state of the art.

Authors:  Yury Zhernov; Mirela Curin; Musa Khaitov; Alexander Karaulov; Rudolf Valenta
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

5.  Resistance of parvalbumin to gastrointestinal digestion is required for profound and long-lasting prophylactic oral tolerance.

Authors:  Raphaela Freidl; Antonia Gstöttner; Ulrike Baranyi; Ines Swoboda; Frank Stolz; Margarete Focke-Tejkl; Thomas Wekerle; Ronald van Ree; Rudolf Valenta; Birgit Linhart
Journal:  Allergy       Date:  2019-10-03       Impact factor: 13.146

Review 6.  IgE-Mediated Fish Allergy in Children.

Authors:  Betul Buyuktiryaki; Marzio Masini; Francesca Mori; Simona Barni; Giulia Liccioli; Lucrezia Sarti; Lorenzo Lodi; Mattia Giovannini; George du Toit; Andreas Ludwig Lopata; Maria Andreina Marques-Mejias
Journal:  Medicina (Kaunas)       Date:  2021-01-18       Impact factor: 2.430

Review 7.  Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?

Authors:  Rudolf Valenta; Alexander Karaulov; Verena Niederberger; Yury Zhernov; Olga Elisyutina; Raffaela Campana; Margarete Focke-Tejkl; Mirela Curin; Leyla Namazova-Baranova; Jiu-Yao Wang; Ruby Pawankar; Musa Khaitov
Journal:  J Allergy Clin Immunol Pract       Date:  2018-10-05

Review 8.  Past, present, and future of allergen immunotherapy vaccines.

Authors:  Yulia Dorofeeva; Igor Shilovskiy; Inna Tulaeva; Margarete Focke-Tejkl; Sabine Flicker; Dmitriy Kudlay; Musa Khaitov; Antonina Karsonova; Ksenja Riabova; Alexander Karaulov; Roman Khanferyan; Winfried F Pickl; Thomas Wekerle; Rudolf Valenta
Journal:  Allergy       Date:  2020-04-29       Impact factor: 13.146
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.